KEQU KEWAUNEE SCIENTIFIC CORP /DE/
Laboratory Apparatus & Furniture · Nasdaq · SEC CIK 55529 · Fiscal year ends 04/30
Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.3%
TTM net income YoY-33.1%
TTM EPS YoY-33.2%
Revenue 3-yr CAGR8.1%
Net income 3-yr CAGR27.6%
Margins
Gross margin28.6%
Operating margin5.4%
Net margin3.0%
FCF margin3.9%
EBITDA margin7.7%
Returns
ROE11.6%
ROA4.5%
ROIC (approx.)13.1%
Asset turnover1.50x
Leverage & solvency
Liabilities / assets56.1%
Debt / equity0.25x
Current ratio2.20x
Interest coverage4.39x
Cash quality & payout
Operating cash flow / net income1.80x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue1.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-07-31 | 2026Q4*2026-04-30 | 2026Q32026-01-31 | 2026Q22025-10-31 | 2026Q12025-07-31 | 2025Q4*2025-04-30 | 2025Q32025-01-31 | 2025Q22024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $66.32M | $71.40M | $69.40M | $70.10M | $71.10M | $77.15M | $67.17M | $47.76M |
| Cost of revenue | $46.68M | $50.16M | $50.85M | $50.38M | $50.17M | $53.11M | $48.79M | $33.81M |
| Gross profit | $19.64M | $21.25M | $18.55M | $19.72M | $20.93M | $24.04M | $18.38M | $13.95M |
| Operating income | $3.16M | $5.22M | $2.58M | $4.11M | $4.81M | $8.50M | $2.25M | $4.43M |
| Interest expense | $626,000 | $631,000 | $1.11M | $1.06M | $1.06M | $1.16M | $1.14M | $442,000 |
| Pretax income | $2.56M | $4.76M | $1.60M | $3.45M | $3.92M | $7.15M | $1.27M | $3.93M |
| Income tax | $717,000 | $1.06M | $528,000 | $915,000 | $761,000 | $2.20M | -$108,000 | $916,000 |
| Net income | $1.71M | $3.39M | $692,000 | $2.44M | $3.09M | $4.85M | $1.35M | $3.01M |
| EBITDA | $4.75M | $6.77M | $4.18M | $5.69M | $6.36M | $10.07M | $3.81M | $5.24M |
| EPS (basic) | 0.59 | — | 0.24 | 0.85 | 1.08 | — | 0.47 | 1.05 |
| EPS (diluted) | 0.58 | — | 0.23 | 0.82 | 1.04 | — | 0.45 | 1.01 |
| Weighted avg. shares (diluted) | 2.92M | — | 2.98M | 2.99M | 2.96M | — | 3.00M | 2.97M |
| Balance sheet | ||||||||
| Cash & equivalents | $8.25M | $9.95M | $8.15M | $12.59M | $20.44M | $17.16M | $12.34M | $29.66M |
| Receivables | $58.20M | $58.74M | $54.13M | $59.02M | $56.90M | $62.38M | $57.42M | $41.88M |
| Inventory | $29.79M | $30.53M | $32.91M | $35.50M | $34.92M | $32.85M | $31.56M | $18.66M |
| Current assets | $103.95M | $105.40M | $103.58M | $113.64M | $117.15M | $118.36M | $108.61M | $96.44M |
| PP&E, net | $21.93M | $22.37M | $22.61M | $23.16M | $22.78M | $23.17M | $23.85M | $16.99M |
| Goodwill | $12.49M | $12.49M | $12.49M | $12.49M | $12.49M | $12.49M | $14.15M | — |
| Intangibles | $15.91M | $16.29M | $16.68M | $17.06M | $17.45M | $17.83M | $18.22M | — |
| Total assets | $175.80M | $178.31M | $175.96M | $189.07M | $193.49M | $194.65M | $189.15M | $134.48M |
| Current liabilities | $47.23M | $48.35M | $48.78M | $45.81M | $50.49M | $53.71M | $50.17M | $36.47M |
| Short-term debt | $5.00M | $5.00M | $5.00M | $3.00M | $3.00M | $3.00M | $3.00M | — |
| Long-term debt | $13.83M | $15.08M | $16.33M | $32.25M | $34.38M | $34.69M | $34.96M | — |
| Total debt | $18.83M | $20.08M | $21.33M | $35.25M | $37.38M | $37.69M | $37.96M | — |
| Total liabilities | $98.58M | $101.50M | $103.43M | $117.36M | $124.62M | $128.41M | $127.03M | $73.82M |
| Shareholders' equity | $75.00M | $74.72M | $70.67M | $69.85M | $67.08M | $64.46M | $60.80M | $59.33M |
| Net debt | $10.59M | $10.13M | $13.18M | $22.66M | $16.94M | $20.52M | $25.63M | — |
| Shares outstanding | 2.90M | 2.87M | 2.87M | 2.87M | 2.87M | 2.84M | 2.87M | 2.87M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.98M | $5.46M | $11.65M | -$4.26M | $5.79M | $9.41M | -$2.27M | $8.44M |
| Capital expenditure | $772,000 | $928,000 | $668,000 | $1.57M | $771,000 | $516,000 | $689,000 | $683,000 |
| Free cash flow | $1.20M | $4.53M | $10.98M | -$5.83M | $5.02M | $8.89M | -$2.96M | $7.75M |
| Investing cash flow | -$772,000 | -$928,000 | -$668,000 | -$1.57M | -$771,000 | -$516,000 | -$29.42M | -$683,000 |
| Financing cash flow | -$2.50M | -$2.95M | -$14.06M | -$853,000 | -$1.46M | -$4.34M | $14.63M | -$3.23M |
| Depreciation & amortization | $1.59M | $1.55M | $1.60M | $1.58M | $1.55M | $1.57M | $1.56M | $806,000 |
| Stock-based compensation | $1.90M | $502,000 | $542,000 | $561,000 | $521,000 | $370,000 | $380,000 | $373,000 |
| Share buybacks | $529,000 | — | — | — | $0 | $1.60M | — | — |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.